Infant & Toddler Synbiotic

About Persephone Biosciences

Persephone Biosciences is a private, commercial-stage biotech company translating microbiome research into direct-to-consumer wellness products. The company's core offering is a scientifically formulated synbiotic for infants, born from its 'My Baby Biome' study, which identified a widespread deficit of beneficial gut bacteria. While currently generating early revenue from product sales, Persephone's long-term strategy appears to be building a data-rich platform to inform future therapeutic and diagnostic applications in the microbiome space. The company is led by its CEO and co-founder, Dr. Stephanie Culler, a microbiome scientist and mother.

Therapeutic Areas